Coronary CT angiography versus standard evaluation in acute chest pain by Woodard, Pamela et al.




Coronary CT angiography versus standard
evaluation in acute chest pain
Pamela Woodard
Washington University School of Medicine in St. Louis
Michael E. Mullins
Washington University School of Medicine in St. Louis
et al
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Woodard, Pamela; Mullins, Michael E.; and et al, ,"Coronary CT angiography versus standard evaluation in acute chest pain." The New
England Journal of Medicine.367,4. 299-308. (2012).
http://digitalcommons.wustl.edu/open_access_pubs/2766
n engl j med 367;4 nejm.org july 26, 2012 299
The new england 
journal of medicine
established in 1812 july 26, 2012 vol. 367 no. 4
Coronary CT Angiography versus Standard Evaluation  
in Acute Chest Pain
Udo Hoffmann, M.D., M.P.H., Quynh A. Truong, M.D., M.P.H., David A. Schoenfeld, Ph.D., Eric T. Chou, M.D., 
Pamela K. Woodard, M.D., John T. Nagurney, M.D., M.P.H., J. Hector Pope, M.D., Thomas H. Hauser, M.D., M.P.H., 
Charles S. White, M.D., Scott G. Weiner, M.D., M.P.H., Shant Kalanjian, M.D., Michael E. Mullins, M.D.,  
Issam Mikati, M.D., W. Frank Peacock, M.D., Pearl Zakroysky, B.A., Douglas Hayden, Ph.D.,  
Alexander Goehler, M.D., Ph.D., Hang Lee, Ph.D., G. Scott Gazelle, M.D., M.P.H., Ph.D., Stephen D. Wiviott, M.D., 
Jerome L. Fleg, M.D., and James E. Udelson, M.D., for the ROMICAT-II Investigators
A BS TR AC T
The authors’ affiliations are listed in the 
Appendix. Address reprint requests to Dr. 
Hoffmann at Massachusetts General Hos-
pital, Cardiac MR PET CT Program, 165 
Cambridge St., Suite 400, Boston, MA 
02114, or at uhoffmann@partners.org.
N Engl J Med 2012;367:299-308.
DOI: 10.1056/NEJMoa1201161
Copyright © 2012 Massachusetts Medical Society.
Background
It is unclear whether an evaluation incorporating coronary computed tomographic 
angiography (CCTA) is more effective than standard evaluation in the emergency 
department in patients with symptoms suggestive of acute coronary syndromes.
Methods
In this multicenter trial, we randomly assigned patients 40 to 74 years of age with 
symptoms suggestive of acute coronary syndromes but without ischemic electrocar-
diographic changes or an initial positive troponin test to early CCTA or to standard 
evaluation in the emergency department on weekdays during daylight hours between 
April 2010 and January 2012. The primary end point was length of stay in the hospi-
tal. Secondary end points included rates of discharge from the emergency depart-
ment, major adverse cardiovascular events at 28 days, and cumulative costs. Safety 
end points were undetected acute coronary syndromes.
Results
The rate of acute coronary syndromes among 1000 patients with a mean (±SD) age 
of 54±8 years (47% women) was 8%. After early CCTA, as compared with standard 
evaluation, the mean length of stay in the hospital was reduced by 7.6 hours 
(P<0.001) and more patients were discharged directly from the emergency depart-
ment (47% vs. 12%, P<0.001). There were no undetected acute coronary syndromes 
and no significant differences in major adverse cardiovascular events at 28 days. 
After CCTA, there was more downstream testing and higher radiation exposure. 
The cumulative mean cost of care was similar in the CCTA group and the standard-
evaluation group ($4,289 and $4,060, respectively; P = 0.65).
Conclusions
In patients in the emergency department with symptoms suggestive of acute 
coronary syndromes, incorporating CCTA into a triage strategy improved the effi-
ciency of clinical decision making, as compared with a standard evaluation in the 
emergency department, but it resulted in an increase in downstream testing and 
radiation exposure with no decrease in the overall costs of care. (Funded by the 
National Heart, Lung, and Blood Institute; ROMICAT-II ClinicalTrials.gov number, 
NCT01084239.)
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T reatment of patients with acute chest pain but an inconclusive initial evalu-ation with the use of biomarkers and elec-
trocardiographic (ECG) testing is often diagnosti-
cally challenging and inefficient. The majority of 
patients with acute coronary syndromes have under-
lying coronary artery disease.1 Contrast-enhanced 
coronary computed tomographic angiography 
(CCTA) has high sensitivity and specificity for the 
detection of clinically significant coronary artery 
disease, as compared with invasive coronary angi-
ography, in patients in stable condition with sus-
pected or known coronary artery disease.2-5
Rule Out Myocardial Infarction/Ischemia Using 
Computer Assisted Tomography (ROMICAT-I),6 a 
blinded observational study involving patients in 
the emergency department with suspected acute 
coronary syndromes, and other studies7,8 have 
shown that normal findings on CCTA have a very 
high negative predictive value for ruling out acute 
coronary syndromes during the index hospitaliza-
tion and the occurrence of major adverse cardio-
vascular events over the next 2 years.7,9 The results 
of two previous randomized, multicenter trials10,11 
suggest that CCTA may facilitate safe and earlier 
triage of low-risk patients and that CCTA can rule 
out coronary artery disease faster than stress 
myocardial-perfusion imaging. However, imaging 
the coronary anatomy with CCTA can involve more 
procedures and greater costs than functional test-
ing.12 Thus, equipoise exists regarding the effec-
tiveness of incorporating CCTA into an evaluation 
strategy in the emergency department.
The objectives of this study were to compare 
the effectiveness of a CCTA-based evaluation strat-
egy with that of standard evaluation in the emer-
gency department for patients with symptoms 
suggestive of an acute coronary syndrome and to 
evaluate the downstream testing, cost, and radia-
tion exposure associated with CCTA.
Me thods
Study Design and Oversight
ROMICAT-II was designed as a randomized, con-
trolled, multicenter trial in which an evaluation and 
management strategy that included CCTA as a 
first diagnostic test performed as early as possible 
was compared with a standard emergency de-
partment evaluation for patients with acute chest 
pain suggestive of an acute coronary syndrome. 
After random assignments had been made to ini-
tial CCTA or standard evaluation without CCTA, 
patient care in both groups was not mandated by 
the study protocol but instead was at the discretion 
of local physicians. The design of ROMICAT-II 
has been described in detail previously,13 and the 
study protocol is available with the full text of 
this article at NEJM.org.
Study Population
Patient enrollment began on April 23, 2010, and 
ended on January 30, 2012, at nine hospitals in 
the United States. All patients provided written 
informed consent to participate in the study. Eli-
gibility criteria were chosen according to the 
ROMICAT-I study,6 with the goal of enrolling a 
population with a similar prevalence of acute 
coronary syndromes (approximately 8%). Eligible 
patients were 40 to 74 years of age, presented to 
the emergency department with chest pain (or 
the anginal equivalent) of at least 5 minutes’ du-
ration within 24 hours before presentation in the 
emergency department, were in sinus rhythm, 
and warranted further risk stratification to rule 
out acute coronary syndromes, as determined by 
an attending physician in the emergency depart-
ment. Major exclusion criteria were a history of 
known coronary artery disease, new diagnostic 
ischemic changes on the initial ECG, an initial 
troponin level in excess of the 99th percentile of 
the local assay, impaired renal function (creati-
nine level, >1.5 mg per deciliter [132.6 µmol per 
liter]), hemodynamic or clinical instability, known 
allergy to an iodinated contrast agent, a body-
mass index (the weight in kilograms divided by 
the square of the height in meters) greater than 
40, or currently symptomatic asthma.
Study Protocol
Eligible patients were identified, provided written 
informed consent, and were randomly assigned 
at their initial evaluation in the emergency depart-
ment during weekday daytime hours. Patients were 
randomly assigned in a 1:1 ratio to either CCTA 
as part of the initial evaluation in the emergency 
department or the standard evaluation strategy 
in the emergency department at that site. All test 
results were provided to emergency department 
physicians in real time. Additional care was not 
mandated by the study protocol in either ran-
domization group.
The discharge diagnosis was based on the lo-
cal physicians’ assessment. The discharge diag-
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noses were adjudicated separately by a clinical 
end-points committee in a predefined sample of 
242 patients, which included all patients with 
acute coronary syndromes, the first 8 patients 
enrolled at each site, 4% of patients discharged 
with cardiac symptoms, and a randomly selected 
subgroup of 10% of all patients. The definitions 
of acute coronary syndromes are provided in the 
Supplementary Appendix, available at NEJM.org.
To ascertain potentially undetected acute coro-
nary syndromes and as a safety measure, patients 
discharged within 24 hours after presentation in 
the emergency department were contacted by tele-
phone within 72 hours to assess their clinical sta-
tus. A follow-up telephone call to all patients was 
also conducted 28 days after discharge. During 
telephone calls, information on repeat visits to 
the emergency department or rehospitalizations 
for recurrent chest pain (including diagnostic 
testing, interventions, and clinical events during 
follow-up) was obtained and verified by the col-
lection of medical records.
CCTA
Before the start of the study, participating sites 
were not routinely performing CCTA in patients 
in the emergency department to detect acute cor-
onary syndromes, but they were required to use 
at least 64-slice CT technology for patient assess-
ment. Protocols involving both retrospectively 
ECG-gated and prospectively ECG-triggered CCTA 
were permitted, with use according to published 
guidelines.14 The use of tube modulation to lower 
radiation exposure was strongly encouraged. CCTA 
images were interpreted on-site in real time, and 
the results were communicated to the responsible 
clinician.
End Points
The prespecified primary end point was the length 
of the hospital stay, defined as the time from 
presentation in the emergency department to the 
time of the discharge order. This end point was 
chosen because it reflects the summary of actions 
taken in response to clinical information and test 
results, as well as logistical, cost, and medical 
and legal considerations in participating centers.
Secondary effectiveness end points included the 
time to diagnosis, defined as the time from pre-
sentation in the emergency department until the 
first diagnostic test that led to the diagnosis of an 
acute coronary syndrome, or as the time from 
presentation in the emergency department to the 
final test that was used to rule out an acute coro-
nary syndrome. The rate of direct discharge from 
the emergency department was defined as the 
proportion of patients discharged from the emer-
gency department without admission to an obser-
vation unit or the hospital. Resource utilization 
was defined as any diagnostic testing (CCTA, ex-
ercise treadmill testing, nuclear imaging, stress 
echocardiography, or cardiac catheterization) or 
interventions from the index assessment in the 
emergency department to follow-up at 28 days, and 
it included resources used during repeat visits to 
the emergency department or hospitalization for 
recurrent chest pain. Cumulative radiation expo-
sure was defined as radiation exposure from 
testing, including CCTA, nuclear perfusion im-
aging, and invasive coronary angiography, mea-
sured in millisieverts and calculated with the 
use of standard methods15 during the index care 
episode (the visit to the emergency department 
and hospitalization) and follow-up. Health care 
costs during the index care episode were assessed 
from reports from hospital cost-accounting sys-
tems and physician billing records and were ad-
justed to 2011 dollars. Mean costs for patient care, 
diagnostic testing, and interventions during the 
1000 Underwent randomization
1273 Patients were assessed for eligibility
273 Were excluded
228 Declined to participate
45 Had administrative
reasons
501 Were assigned to CCTA (473 [94%]
underwent CCTA as a first test)
499 Were assigned to standard
evaluation in emergency department
497 (99%) Were included
in 28-day follow-up
490 (98%) Were included
in 28-day follow-up
Figure 1. Screening, Randomization, and Follow-up of the Study Patients.
CCTA denotes coronary computed tomographic angiography.
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index care episode were used to estimate the 
costs during follow-up.
Safety variables prespecified as secondary 
end points included an undetected acute coro-
nary syndrome (defined as an unexpected car-
diovascular event within 72 hours after hospital 
discharge in patients with a hospital stay of <24 
hours), to ensure that potentially earlier discharge 
in the CCTA group was not associated with in-
creased adverse events, major adverse cardiovas-
cular events (defined as death, myocardial in-
farction, unstable angina, or urgent coronary 
revascularization within 28 days), and periproce-
dural complications (stroke, bleeding, anaphylaxis, 
or renal failure). These predefined safety variables 
were adjudicated by an external, independent 
clinical-events committee.
Statistical Analyses
All statistical analyses were performed by an in-
dependent data coordinating center on the basis 
of an intention-to-treat analysis. Continuous data 
are presented as means ±SD and medians with 
interquartile ranges. Comparisons between groups 
were performed with the use of an independent-
sample t-test for continuous variables, Fisher’s 
exact test for categorical variables, and the Wil-
coxon rank-sum test for ordinal variables. A two-
sided P value of less than 0.05 was considered to 
indicate statistical significance. Concordance be-
tween the discharge diagnosis made at the study 
site and the independently adjudicated diagnosis 
in a selected subpopulation was assessed with 
the use of the kappa statistic.
The study was designed to have greater than 
83% power with the use of a t-test at a two-sided 
5% significance level if the true between-group 
difference in the length of stay in the hospital was 
at least 8.3 hours. Details of the simulation are 
described elsewhere.13
The study did not have predefined stopping 
rules or boundaries with respect to the primary 
end point or safety end points. Rather, the data 
and safety monitoring board was responsible for 






(N = 499) P Value
Mean age — yr 54±8 54±8 0.44
Female sex — % 48 46 0.57
Race or ethnic group — no. (%)
Black 141 (28) 141 (28) 1.00
White 330 (66) 330 (66) 0.95
Asian 18 (4) 13 (23) 0.47
Other 12 (2) 18 (4) 0.27
Non-Hispanic 435 (87) 422 (85) 0.57
Cardiovascular risk factors — no. (%)
Hypertension 269 (54) 272 (54) 0.80
Diabetes mellitus 86 (17) 87 (17) 0.93
Dyslipidemia 230 (46) 224 (45) 0.75
Former or current smoker 249 (50) 243 (49) 0.75
Family history of premature coronary artery disease 135 (27) 136 (27) 0.94
No. of cardiovascular risk factors — % 0.68
0 or 1 36 38
2 or 3 54 52
≥4 10 10
Relevant prior medication — no. (%)
Aspirin 115 (23) 113 (23) 0.94
Beta-blocker 88 (18) 82 (16) 0.67
Statin 143 (28) 151 (30) 0.58 
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assessing every case in which an acute coronary 
syndrome might have been undetected.
R esult s
Study Population
Of 1000 enrolled patients, 501 were randomly as-
signed to CCTA and 499 were randomly assigned 
to a standard evaluation in the emergency depart-
ment. All patients were included in the intention-
to-treat analysis (Fig. 1). CCTA was not performed 
in 28 patients (6%) because of the patient’s deci-
sion to decline CCTA (9 patients), safety concerns 
(5 patients), unavailability of CCTA (5 patients), 
or technical difficulties (9 patients). Overall, 987 of 
1000 randomly assigned patients (99%) had com-
plete follow-up at 28 days. The original medical 
records for repeat visits to the emergency depart-
ment or hospitalizations were available in all cases.
Baseline characteristics of the study population 
are shown in Table 1. After a complete evalua-
tion, 75 patients (8%) had a final diagnosis of an 
acute coronary syndrome. Agreement between the 
site and independent adjudication for the discharge 
diagnosis was very high (concordance, 98% [236 of 
242 patients]; kappa, 0.94).
Primary and Secondary Effectiveness  
End Points
The effectiveness end points are shown in Table 2. 
The primary end point met the prespecified crite-
rion for significance, since the average length of 
the hospital stay in the group of patients ran-
domly assigned to CCTA was decreased by 7.6 
hours, as compared with the group randomly as-
signed to a standard emergency department eval-
uation (P<0.001). Figure 2 shows the cumulative 
distribution of discharged patients with length-
of-stay data in the two groups. Notably, 50% of 
the patients in the CCTA group were discharged 
within 8.6 hours after presentation, as compared 
with 10% of the patients randomly assigned to a 
standard evaluation in the emergency depart-
ment. In the subgroup of patients with a final 
diagnosis of an acute coronary syndrome, the 







(N = 499) P Value
Initial presentation in emergency department
Chief symptom — no. (%) 0.47
Radiating or nonradiating chest pain or anginal equivalent 444 (89) 452 (91)
Arm, jaw, shoulder, or epigastric pain 21 (4) 16 (3)
Shortness of breath 7 (1) 10 (2)
Other 29 (6) 21 (4)
Heart rate — beats/min 78±14 77±14 0.58
Blood pressure — mm Hg
Systolic 144±23 144±23 0.80
Diastolic 83±13 83±13 0.94
BMI 29.4±5.3 29.1±4.8 0.41
Discharge diagnosis after index emergency department visit or hospital-
ization — no. (%)
0.16
Noncardiac chest pain 426 (85) 445 (89)
Noncoronary cardiac pain 7 (1) 8 (2)
Coronary chest pain not associated with acute coronary syndrome 25 (5) 14 (3)
Acute coronary syndrome 43 (9) 32 (6)
Unstable angina pectoris 35 (7) 17 (3)
Myocardial infarction 8 (2) 15 (3)
* Plus–minus values are means ±SD. BMI denotes body-mass index (the weight in kilograms divided by the square of the 
height in meters), and CCTA coronary computed tomographic angiography.
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CCTA and after standard evaluation in the emer-
gency department.
In the overall cohort and also in the sub-
groups with or without a final diagnosis of an 
acute coronary syndrome, the mean time to diag-
nosis was significantly decreased with CCTA as 
compared with a standard evaluation. Patients in 
the CCTA group were more often directly dis-






(N = 499) P Value
Length of hospital stay — hr
All patients in intention-to-treat analysis <0.001
Mean 23.2±37.0 30.8±28.0
Median 8.6 26.7
Interquartile range 6.4–27.6 21.4–30.6
Patients with final diagnosis other than acute coronary syndrome <0.001
Mean 17.2±24.6 27.2±19.5
Median 8.1 26.3
Interquartile range 6.2–24.6 20.6–29.5
Patients with final diagnosis of acute coronary syndrome 0.87
Mean 86.3±72.3 83.8±61.3
Median 56.9 71.8
Interquartile range 46.2–95.9 45.2–96.7
Time to diagnosis — hr
All patients in intention-to-treat analysis <0.001
Mean 10.4±12.6 18.7±11.8
Median 5.8 21.0
Interquartile range 4.0–9.0 8.5–23.8
Patients with final diagnosis other than acute coronary syndrome <0.001
Mean 10.6±12.3 18.8±12.0
Median 6.1 21.1
Interquartile range  4.0–9.6 8.7–23.8
Patients with final diagnosis of acute coronary syndrome 0.002
Mean 8.0±15.1 17.1±9.5
Median 4.4 14.9
Interquartile range 3.3–5.6 7.4–25.1
Discharge status — no. (%) <0.001
Direct discharge from emergency department 233 (47) 62 (12)
Admission to observation unit 153 (30) 301 (60)
Admission to hospital 107 (21) 125 (25)
Left against medical advice 8 (2) 11 (2)
Follow-up for recurrent chest pain within 28 days — no.
Repeat visit to emergency department 14 19 0.38
Repeat hospitalization 7 7
Safety — no.
Undetected acute coronary syndrome 0 0
Periprocedural complications 2 0 0.50
Major adverse cardiovascular events at 28 days — no. 2 6 0.18
* Plus–minus values are means ±SD.
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charged from the emergency department (47%, vs. 
12% of patients in the standard-evaluation group; 
P<0.001), with fewer admissions to an observa-
tion unit.
Safety End Points
Prespecified clinical adverse events were infre-
quent in this trial (Table 2). No cases of undetect-
ed acute coronary syndromes were identified in 
either study group. Overall, there were eight ma-
jor adverse cardiovascular events during the 28-
day follow-up: six after standard evaluation in 
the emergency department (four myocardial in-
farctions and two cases of unstable angina pec-
toris for which percutaneous coronary interven-
tion was required) and two after CCTA (one 
myocardial infarction and one case of unstable 
angina pectoris for which percutaneous coronary 
intervention was required) (P = 0.18). In both of 
the latter patients, CCTA established clinically sig-
nificant coronary artery disease during the index 
hospitalization, but both patients had negative 
stress tests and were initially treated medically. 
Two periprocedural complications occurred in the 
CCTA group (perioperative bleeding after cardio-
thoracic surgery for an identified anomalous coro-
nary artery and a transient increase in the creati-
nine level after CCTA without the need for dialysis 
in a patient with a urethral stone and hydrone-
phrosis), and no periprocedural complications 
occurred in the standard-evaluation group.
Resource Utilization and Radiation Exposure
Table 3 shows resource utilization. Overall, more 
diagnostic testing was performed in the CCTA 
group than in the standard-evaluation group 
(P<0.001). Both the cumulative rate of invasive 
coronary angiography during the index hospital-
ization and follow-up and the rate of coronary 
revascularization were higher among patients in 
the CCTA group than among patients in the stan-
dard-evaluation group, but the differences were 
not significant (P = 0.06 and P = 0.16, respectively) 
(Table 3).
Nearly all patients in the CCTA group (484 of 
501 patients; 97%), but only 167 of 499 patients 
randomly assigned to standard evaluation (33%) 
received radiation exposure from an imaging test 
or procedure. Hence, cumulative radiation expo-
sure was significantly higher in the CCTA group 
(Table 3). The mean radiation exposure from 
CCTA was 11.3±5.3 mSv and was lower than that 
from single-photon-emission CT (14.1±4.8 mSv, 
P<0.001). The 78 patients who underwent CCTA 
with the use of an advanced 128-slice, dual-
source CT scanner had lower radiation exposure 
(6.2±3.8 mSv) than did the remaining patients 
(12.3±5 mSv).
Detailed cost data were available in a subgroup 
of all 649 patients from five centers (Table 3). 
The mean costs of care from the initial visit in 
the emergency department through the 28-day 
follow-up were similar in the CCTA group and 
the group that received standard evaluation in 
the emergency department (P = 0.65).
Discussion
This prospective, multicenter, randomized, strat-
egy-controlled trial was designed primarily to as-
sess whether CCTA, incorporated early into an 
evaluation strategy for patients presenting to an 
emergency department with chest pain sugges-
tive of an acute coronary syndrome, safely im-
proves the efficiency of clinical decision making, 
as compared with a standard evaluation in the 
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Figure 2. Length of Stay in the Hospital and Proportion of Patients 
Discharged.
The cumulative frequency of discharge from the index visit according to the 
length of stay is shown. The horizontal line indicates the median length of 
stay in the two study groups, which was significantly different (8.6 hours in 
the CCTA group vs. 26.7 hours in the standard-evaluation group, P<0.001).
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diagnostic tests, interventions, and radiation ex-
posure were also evaluated. The average length of 
stay in the hospital, the primary end point of the 
trial, was significantly reduced in the CCTA 
group, as was the time to diagnosis. Further-
more, rates of direct discharge from the emer-
gency department were higher with CCTA than 
with a standard evaluation in the emergency de-
partment. These results were achieved without 
putting patients at greater risk for undetected 
acute coronary syndromes and without an in-
crease in the cost of care. However, we observed 
increased diagnostic testing in the CCTA group 
and increased radiation exposure.
An important consideration when results show 
more efficient triage is whether that gain is 
achieved at the risk of undetected acute coronary 
syndromes. There were no undetected cases of 
acute coronary syndromes in either study group, 
suggesting that the earlier and greater number 
of discharges in the CCTA group did not result in 
any missed diagnoses. More major adverse cardio-
vascular events were observed in the standard-
evaluation group than in the CCTA group, 
Table 3. Resource Utilization, Radiation Exposure, and Costs of Care.*










(N = 499) P Value
Diagnostic testing — no. of patients (%)† <0.001 <0.001
No testing‡ 9 (2) 109 (22) 9 (2) 89 (18)
1 test 376 (75) 337 (68) 359 (72) 350 (70)
≥2 tests 116 (23) 53 (11) 133 (27) 60 (12)
Functional testing — no. (%)§ <0.001 <0.001
SPECT 50 (10) 124 (25) 58 (12) 133 (27)
Stress echocardiography 20 (4) 102 (20) 20 (4) 102 (20)
ETT 12 (2) 147 (29) 22 (4) 162 (32)
Invasive coronary angiography — no. (%) 54 (11) 36 (7) 0.06 59 (12) 40 (8) 0.06
Intervention — no. (%)
PCI 24 (5) 14 (3) 0.14 27 (5) 17 (3) 0.16
CABG 5 (1) 4 (1) 0.99 5 (1) 4 (1) 0.99
Cumulative radiation exposure — mSv/patient¶ 13.9±10.4 4.7±8.4 <0.001 14.3±10.9 5.3±9.6 <0.001








Mean 4,026±6,792 3,874±5,298 4,289±7,110 4,060±5,452
Median 1,937 2,742 1,946 2,809
Interquartile range 1,504–4,057 1,755–3,832 1,514–4,164 1,822–4,060
* Plus–minus values are means ±SD. Percentages may not sum to 100 because of rounding. CABG denotes coronary-artery bypass grafting, 
ETT exercise treadmill testing, PCI percutaneous coronary intervention, and SPECT single-photon-emission computed tomography.
† Diagnostic testing included CCTA, ETT, SPECT, stress echocardiography, and invasive coronary angiography.
‡ Serial measurement of biomarkers and electrocardiographic testing were not considered as diagnostic tests in this table.
§ At the index visit, functional testing was the second test in the CCTA group and the first test in the standard-evaluation group.
¶ Radiation exposure included exposure from CCTA, SPECT, and invasive coronary angiography.
║‖ Costs included those for patients discharged directly from the emergency department and those discharged from an observation unit.
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though the study did not have the statistical 
power to support the conclusion that major ad-
verse cardiovascular events may be reduced after 
a CCTA-based evaluation.
The prevalence of acute coronary syndromes in 
a patient population is an important determinant 
of the risk–benefit ratio, given that CCTA is an 
advanced diagnostic imaging test that entails the 
administration of iodinated contrast material, ra-
diation exposure, and costs. In our study popu-
lation of patients who were at intermediate risk 
for acute coronary syndromes (observed rate of 
acute coronary syndromes, 7.5%, vs. 2 and 4% in 
previous studies10,11), a greater number of invasive 
coronary procedures were performed after CCTA 
than after a standard evaluation. Information on 
the presence of anatomical coronary artery disease 
may influence clinical decision making toward 
invasive angiography. This concept is consistent 
with recent data suggesting that in a Medicare 
population, imaging of the coronary anatomy with 
CCTA in a nonemergency setting led to greater use 
of downstream testing and procedures, as com-
pared with functional stress testing.12
In this trial, no decrease in total costs for the 
index visit and during 28-day follow-up was ob-
served in a subgroup of 649 patients from five of 
nine sites in which complete billing data were 
available. Long-term outcome data are not avail-
able; such data might have allowed a determina-
tion of whether CCTA results in fewer repeat 
visits to the emergency department and hospital-
izations over a longer time course.
Cumulative radiation exposure was higher in 
the group randomly assigned to CCTA than in the 
standard-evaluation group. Recent data show that 
diagnostic-quality CCTA imaging can be per-
formed with exposure of less than 5 mSv in se-
lected patients; this suggests that future studies 
could use lower doses of radiation.16,17 Lower-
dose radiation should be considered in efforts to 
apply this strategy more widely, as well as in 
particular groups of patients.
There are several limitations of the present 
study and analysis. Enrollment occurred only dur-
ing weekday hours when all imaging testing was 
available with technologists and readers on site. 
However, the results of triage decision making 
and particularly the timing of decisions to dis-
charge or hospitalize patients would probably be 
different if the imaging studies were carried out 
during the night, when testing and interpretation 
are not as accessible. Similarly, the results cannot 
be generalized to clinical sites that perform a 
dedicated accelerated diagnostic protocol18 in the 
standard evaluation.
Inherent in the design of any randomized, 
comparative-effectiveness trial assessing a testing 
procedure is the lack of blinding to the interven-
tion. We acknowledge that there may have been a 
bias in decision making toward earlier discharge 
in the CCTA group. For both groups of patients, 
however, the decision making was left to a large 
number of clinicians at the nine sites who were 
not directly associated with the study and whose 
decisions were subject to the same imperatives to 
provide high-quality clinical care and to take into 
account medical and legal considerations. Finally, 
the results of this study may not be applicable to 
populations that we did not study, including pa-
tients younger than 40 years of age and those 
older than 74 years of age.
In conclusion, in this trial involving patients 
with suspected acute coronary syndromes, an 
evaluation strategy incorporating early CCTA, as 
compared with a standard evaluation strategy, 
improved the efficiency of clinical decision mak-
ing for triage in the emergency department, with 
a shorter length of stay in the hospital and more 
direct discharges from the emergency department. 
This improvement appeared to be accomplished 
safely, without putting patients at greater risk for 
undetected acute coronary syndromes. There was 
increased diagnostic testing and higher radiation 
exposure in the CCTA group, with no overall 
reduction in the cost of care. These data should 
allow providers and patients to make informed 
decisions about the use of this technology as an 
option for evaluation when symptoms are sugges-
tive of an acute coronary syndrome.
Supported by grants from the National Heart, Lung, and 
Blood Institute (U01HL092040 and U01HL092022) and the Na-
tional Institutes of Health (UL1RR025758, K23HL098370, and 
L30HL093896, to Dr. Truong).
Dr. Gazelle reports receiving consulting fees from GE Health-
care; Dr. Hauser, receiving consulting fees from Astellas and the 
Harvard Clinical Research Institute; Dr. Hoffmann, receiving 
grant support from the American College of Radiology Imaging 
Network, Bracco Diagnostics, Genentech, and Siemens Health-
care on behalf of his institution; Dr. Nagurney, receiving grant 
support from Alere (Biosite), Brahms Diagnostica (Fischer), and 
Nanosphere on behalf of his institution; Dr. Truong, receiving 
grant support from St. Jude Medical and Qi Imaging on behalf of 
her institution and travel support from Medconvent and the So-
ciety of Cardiac Computed Tomography; Dr. Wiviott, receiving 
consulting fees from Arena Pharmaceuticals, AstraZeneca, Bayer, 
Bristol-Myers Squibb, and Ortho-McNeil, grant support from 
The New England Journal of Medicine 
Downloaded from nejm.org at WASHINGTON UNIV SCH MED MEDICAL LIB on April 26, 2014. For personal use only. No other uses without permission. 
 Copyright © 2012 Massachusetts Medical Society. All rights reserved. 
n engl j med 367;4 nejm.org july 26, 2012308
coronary CT Angiogr aphy for Acute Chest Pain
appendix
The author’s affiliations are as follows: the Department of Radiology (U.H., P.Z., A.G., G.S.G.), the Cardiac MR PET CT Program (U.H., 
Q.A.T., P.Z., A.G.), the Division of Cardiology (U.H., Q.A.T.), the Department of Emergency Medicine (J.T.N.), the Biostatistics Center 
(D.A.S., D.H., H.L.), and the Institute of Technology Assessment (A.G., G.S.G.), Massachusetts General Hospital, Boston; Harvard 
Medical School, Boston (U.H., Q.A.T., D.A.S., T.H.H., A.G., H.L., G.S.G., S.D.W.); the Department of Emergency Medicine, Baystate 
Medical Center, Springfield, MA (J.H.P.); the Cardiovascular Institute, Beth Israel Deaconess Medical Center, Boston (T.H.H.); the De-
partment of Emergency Medicine (S.G.W.) and the Division of Cardiology and the CardioVascular Center (J.E.U.), Tufts Medical Center, 
Boston; and the Cardiovascular Division, Brigham and Women’s Hospital, Boston (S.D.W.); Kaiser Permanente Fontana Medical Center, 
Fontana, CA (E.T.C., S.K.); Mallinckrodt Institute of Radiology (P.K.W.) and the Division of Emergency Medicine (M.E.M.), Washington 
University School of Medicine, St. Louis; University of Maryland School of Medicine, Baltimore (C.S.W.); the Division of Cardiovascular 
Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (J.L.F.); the Department of Emergency Medicine, Department of 
Medicine, Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago (I.M.); the Department 
of Emergency Medicine, Baylor College of Medicine, Houston (W.F.P.); and the Thrombolysis in Myocardial Infarction (TIMI) Study 
Group, Boston (S.D.W.).
AstraZeneca, Daiichi Sankyo, Eli Lilly, and Merck and Schering-
Plough on behalf of his institution, and lecture fees from Astra-
Zeneca, Daiichi Sankyo, Eli Lilly, Novartis, and Schering-
Plough; and Dr. Udelson, being on the scientific advisory board 
of Lantheus Medical Imaging. No other potential conflict of in-
terest relevant to this article was reported.
Disclosure forms provided by the authors are available with 
the full text of this article at NEJM.org.
References
1. Roe MT, Harrington RA, Prosper DM, 
et al. Clinical and therapeutic profile of 
patients presenting with acute coronary 
syndromes who do not have significant 
coronary artery disease. Circulation 2000; 
102:1101-6.
2. Miller JM, Rochitte CE, Dewey M, et 
al. Diagnostic performance of coronary 
angiography by 64-row CT. N Engl J Med 
2008;359:2324-36.
3. Budoff MJ, Dowe D, Jollis JG, et al. 
Diagnostic performance of 64-multidetec-
tor row coronary computed tomographic 
angiography for evaluation of coronary ar-
tery stenosis in individuals without known 
coronary artery disease: results from the 
prospective multicenter ACCURACY (As-
sessment by Coronary Computed Tomo-
graphic Angiography of Individuals Under-
going Invasive Coronary Angiography) 
trial. J Am Coll Cardiol 2008;52:1724-32.
4. Marano R, De Cobelli F, Floriani I, et 
al. Italian multicenter, prospective study 
to evaluate the negative predictive value of 
16- and 64-slice MDCT imaging in pa-
tients scheduled for coronary angiogra-
phy (NIMISCAD-Non Invasive Multicenter 
Italian Study for Coronary Artery Dis-
ease). Eur Radiol 2009;19:1114-23.
5. Meijboom WB, Meijs MF, Schuijf JD, 
et al. Diagnostic accuracy of 64-slice com-
puted tomography coronary angiography: 
a prospective, multicenter, multivendor 
study. J Am Coll Cardiol 2008;52:2135-44.
6. Hoffmann U, Bamberg F, Chae CU, et 
al. Coronary computed tomography angi-
ography for early triage of patients with 
acute chest pain: the ROMICAT (Rule Out 
Myocardial Infarction using Computer 
Assisted Tomography) trial. J Am Coll 
Cardiol 2009;53:1642-50.
7. Hollander JE, Chang AM, Shofer FS, et 
al. One-year outcomes following coronary 
computerized tomographic angiography 
for evaluation of emergency department 
patients with potential acute coronary syn-
drome. Acad Emerg Med 2009;16:693-8.
8. Rubinshtein R, Halon DA, Gaspar T, 
et al. Usefulness of 64-slice cardiac com-
puted tomographic angiography for diag-
nosing acute coronary syndromes and 
predicting clinical outcome in emergency 
department patients with chest pain of 
uncertain origin. Circulation 2007;115: 
1762-8.
9. Schlett CL, Banerji D, Siegel E, et al. 
Prognostic value of CT angiography for 
major adverse cardiac events in patients 
with acute chest pain from the emergency 
department: 2-year outcomes of the 
ROMICAT trial. JACC Cardiovasc Imaging 
2011;4:481-91.
10. Goldstein JA, Chinnaiyan KM, Abidov 
A, et al. The CT-STAT (Coronary Com-
puted Tomographic Angiography for Sys-
tematic Triage of Acute Chest Pain Patients 
to Treatment) trial. J Am Coll Cardiol 
2011;58:1414-22.
11. Litt HI, Gatsonis C, Snyder B, et al. CT 
angiography for safe discharge of pa-
tients with possible acute coronary syn-
dromes. N Engl J Med 2012;366:1393-403.
12. Shreibati JB, Baker LC, Hlatky MA. 
Association of coronary CT angiography 
or stress testing with subsequent utiliza-
tion and spending among Medicare ben-
eficiaries. JAMA 2011;306:2128-36.
13. Hoffmann U, Truong QA, Fleg JL, et 
al. Design of the Rule Out Myocardial 
Ischemia/Infarction Using Computer As-
sisted Tomography: a multicenter ran-
domized comparative effectiveness trial 
of cardiac computed tomography versus 
alternative triage strategies in patients 
with acute chest pain in the emergency 
department. Am Heart J 2012;163:330-8.
14. Abbara S, Arbab-Zadeh A, Callister 
TQ, et al. SCCT guidelines for perfor-
mance of coronary computed tomograph-
ic angiography: a report of the Society of 
Cardiovascular Computed Tomography 
Guidelines Committee. J Cardiovasc 
Comput Tomogr 2009;3:190-204.
15. Gerber TC, Carr JJ, Arai AE, et al. Ion-
izing radiation in cardiac imaging: a sci-
ence advisory from the American Heart 
Association Committee on Cardiac Imag-
ing of the Council on Clinical Cardiology 
and Committee on Cardiovascular Imag-
ing and Intervention of the Council on 
Cardiovascular Radiology and Interven-
tion. Circulation 2009;119:1056-65.
16. von Ballmoos MW, Haring B, Juillerat 
P, Alkadhi H. Meta-analysis: diagnostic per-
formance of low-radiation-dose coronary 
computed tomography angiography. Ann 
Intern Med 2011;154:413-20. [Erratum, 
Ann Intern Med 2011;154:848.]
17. Achenbach S, Marwan M, Ropers D, 
et al. Coronary computed tomography an-
giography with a consistent dose below 
1  mSv using prospectively electrocardio-
gram-triggered high-pitch spiral acquisi-
tion. Eur Heart J 2010;31:340-6.
18. Than M, Cullen L, Reid CM, et al. A 
2-h diagnostic protocol to assess patients 
with chest pain symptoms in the Asia-
Pacific region (ASPECT): a prospective 
observational validation study. Lancet 
2011;377:1077-84.
Copyright © 2012 Massachusetts Medical Society.
The New England Journal of Medicine 
Downloaded from nejm.org at WASHINGTON UNIV SCH MED MEDICAL LIB on April 26, 2014. For personal use only. No other uses without permission. 
 Copyright © 2012 Massachusetts Medical Society. All rights reserved. 
